7連板永悦科技(603879.SH):主要的收入來源於不飽和聚酯樹脂為主的主業
格隆匯3月20日丨永悦科技(603879.SH)公佈股票交易風險提示公吿,公司股票自2024年3月12日至2024年3月20日,已連續7個交易日升停,公司股價升幅95.29%,公司主營業務為以不飽和聚酯樹脂為主的合成樹脂的研發、生產和銷售以及無人機業務兩大版塊業務。截至2023年第三季度,公司無人機業務營業收入約為280萬元,尚未給上市公司營業收入帶來重大影響。公司主要的收入來源於不飽和聚酯樹脂為主的主業,請廣大投資者注意概念炒作風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.